Yang Shuai, Guan Ting, Yang HuanYi, Hu YiRong, Zhao Yan
School of Sports Medicine and Health, Chengdu Sport University, Chengdu, China.
Department of Endocrinology and Metabolism, West Chengdu Hospital, Chengdu, China.
Front Med (Lausanne). 2024 Mar 8;11:1349615. doi: 10.3389/fmed.2024.1349615. eCollection 2024.
We report a case of overlooked Subacute Thyroiditis (SAT) potentially induced by the administration of a COVID-19 vaccine. This case prompted a thorough review of the existing literature to elucidate possible mechanisms by which immune responses to the COVID-19 vaccine might precipitate thyroid damage. The primary objective is to enhance the clinical understanding and awareness of SAT among healthcare professionals. Subacute thyroiditis is a prevalent form of self-limiting thyroid disorder characterized by fever, neck pain or tenderness, and palpitations subsequent to viral infection. The development of numerous SARS-CoV-2 vaccines during the COVID-19 pandemic was intended to mitigate the spread of the virus. Nevertheless, there have been documented instances of adverse reactions arising from SARS-CoV-2 vaccines, such as the infrequent occurrence of subacute thyroiditis. While the majority of medical practitioners can discern classic subacute thyroiditis, not all cases exhibit typical characteristics, and not all systematic treatments yield positive responses. In this study, we present a rare case of subacute thyroiditis linked to the administration of the SARS-CoV-2 vaccine. A previously healthy middle-aged female developed fever and sore throat 72 h post-inoculation with the inactivated SARS-CoV-2 vaccine. Initially attributing these symptoms to a common cold, she self-administered ibuprofen, which normalized her body temperature but failed to alleviate persistent sore throat. Suspecting a laryngopharyngeal disorder, she sought treatment from an otolaryngologist. However, the pain persisted, accompanied by intermittent fever over several days. After an endocrinology consultation, despite the absence of typical neck pain, her examination revealed abnormal thyroid function, normal thyroid antibodies, heterogeneous echogenicity on thyroid ultrasonography, and elevated levels of Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP). These findings led to a consideration of the diagnosis of SAT. Initially, she was treated with non-steroidal anti-inflammatory drugs (NSAIDs) for her fever, which proved effective, but her neck pain remained uncontrolled. This suggested a poor response to NSAIDs. Consequently, steroid therapy was initiated, after which her symptoms of fever and neck pain rapidly resolved.
我们报告了一例可能由新冠疫苗接种引发的被忽视的亚急性甲状腺炎(SAT)病例。该病例促使我们对现有文献进行全面回顾,以阐明针对新冠疫苗的免疫反应可能导致甲状腺损伤的潜在机制。主要目的是提高医疗专业人员对亚急性甲状腺炎的临床认识和警觉性。亚急性甲状腺炎是一种常见的自限性甲状腺疾病,其特征为病毒感染后出现发热、颈部疼痛或压痛以及心悸。在新冠疫情期间研发了多种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗,旨在减轻病毒传播。然而,已有记录表明SARS-CoV-2疫苗会引发不良反应,例如偶发亚急性甲状腺炎。虽然大多数医生能够识别典型的亚急性甲状腺炎,但并非所有病例都表现出典型特征,而且并非所有系统治疗都能产生积极效果。在本研究中,我们呈现了一例与SARS-CoV-2疫苗接种相关的罕见亚急性甲状腺炎病例。一名既往健康的中年女性在接种灭活SARS-CoV-2疫苗72小时后出现发热和咽痛。最初她将这些症状归因于普通感冒,自行服用布洛芬后体温恢复正常,但持续的咽痛并未缓解。怀疑患有咽喉部疾病,她前往耳鼻喉科医生处就诊。然而,疼痛持续存在,并伴有数天的间歇性发热。在内分泌科会诊后,尽管没有典型的颈部疼痛,但她的检查显示甲状腺功能异常、甲状腺抗体正常、甲状腺超声检查显示回声不均匀,以及红细胞沉降率(ESR)和C反应蛋白(CRP)水平升高。这些发现促使考虑诊断为亚急性甲状腺炎。最初她接受了非甾体抗炎药(NSAIDs)治疗发热,证明有效,但颈部疼痛仍未得到控制。这表明对NSAIDs反应不佳。因此,开始使用类固醇治疗,之后她的发热和颈部疼痛症状迅速缓解。